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ABSTRACT
Background: To improve patient safety, organisations
must systematically measure avoidable harms. Clinical
surveillancedconsisting of prospective case ﬁnding
and peer reviewdcould improve identiﬁcation of
adverse events (AEs), preventable AEs and potential
AEs. The authors sought to describe and compare
ﬁndings of clinical surveillance on four clinical services
in an academic hospital.
Methods: Clinical surveillance was performed by a nurse
observer who monitored patients for prespeciﬁed
clinical events and collected standard information about
each event. A multidisciplinary, peer-review committee
rated causation for each event. Events were
subsequently classiﬁed in terms of severity and type.
Results: The authors monitored 1406 patients during
their admission to four hospital services: Cardiac
Surgery Intensive Care (n¼226), Intensive Care
(n¼211), General Internal Medicine (n¼453) and
Obstetrics (n¼516). The authors detected 245 AEs
during 9300 patient days of observation (2.6 AEs per
100 patient days). 88 AEs (33%) were preventable. The
proportion of patients experiencing at least one AE,
preventable AE or potential AE was 13.7%, 6.1% and
5.3%, respectively. AE risk varied between services,
ranging from 1.4% of Obstetrics to 11% of Internal
Medicine and Intensive Care patients experiencing at
least one preventable AE. The proportion of patients
experiencing AEs resulting in permanent disability or
death varied between services: ranging from 0.2% on
Obstetrics to 4.9% on Cardiac Surgery Intensive Care.
No services shared the most frequent AE type.
Conclusions: Using clinical surveillance, the authors
identiﬁed a high risk of AE and signiﬁcant variation in
AE risks and subtypes between services. These
ﬁndings suggest that institutions will need to evaluate
service-speciﬁc safety problems to set priorities and
design improvement strategies.
INTRODUCTION
Improving patient safety requires the mini-
misation of treatment-related harm. This is
typically measured as adverse events (AEs)
(harms caused by medical care), preventable
AEs (harm caused by errors) and potential
AEs (errors with the potential for harm).
Numerous studies have demonstrated a high
incidence of AEs and preventable AEs in
hospitalised patients.
1e8 These studies have
prompted signiﬁcant investments to improve
patient safety.
Detection of AEs and preventable AEs is
a primary step to achieving a safe healthcare
system. By systematically measuring these
outcomes and analysing their causes, health-
care planners may design system changes to
prevent them.
9e14 Unfortunately, most
hospitals and health systems have rudimen-
tary approaches to identify AEs. These
approaches include the use of voluntary
reporting, chart reviews and scanning of
administrative data.
15 Each of these methods
has important limitations including a failure
to report, inconsistent peer review and poor
speciﬁcity for patient safety problems.
13 15e23
Detecting AEs is especially challenging
because of the invisible nature of treatment-
related harm. When a patient experiences
a poor outcome, it is often assumed the
outcome was caused by the underlying
disease process. While this is often true,
careful peer review will often determine that
medical care was, at least, partially respon-
sible. Furthermore, adverse outcomes and
the circumstances leading to them are often
not systematically documented. This will
often lead to disagreement between peers
when chart review is used to identify AEs.
24 25
Clinical surveillance is a promising method
of AE detection. In this method, patients and
providers are directly and indirectly moni-
tored by a trained observer prospec-
tively.
26e29 As soon as clinical events are
identiﬁed, the observer records prespeciﬁed
information to facilitate subsequent peer
review. This avoids missing information that
occurs from incomplete documentation in
the patient record.
< Additional appendices are
published online only. To
view these ﬁles please visit
the journal online (http://
qualitysafety.bmj.com).
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Original researchClinical surveillance has several advantages over
existing AE detection methods. It consists of active
surveillance rather than relying solely on voluntary
reporting; it ensures timely collection of information
relevant to case classiﬁcation rather than retrospectively
relying on what is documented in charts, and it enhances
peer review through timely review of cases when
reviewers still remember the case. On the other hand,
although it has been used successfully for years in
tracking surgical complications and healthcare-associ-
ated infections, it has not been widely adopted for all AE
types in multiple, diverse settings.
In this study, we describe our ﬁndings from imple-
menting clinical surveillance in our healthcare facility.
We describe a general process and the results obtained
during its application in four diverse services at an
academic hospital. The comparison of results between
services was of particular interest, as it would validate our
ability to learn useful information from the programme
and would direct strategies for improvement.
METHODS
This study took place at a 1000-bed multicampus urban-
based academic hospital. The hospital provides tertiary-
level patient care, including organ transplants, and is
a Level 1 trauma centre. We performed our clinical
surveillance activities as part of a research study, which
was approved by the Ottawa Hospital Research Ethics
Board.
Overview
We conducted surveillance sequentially on the following
four services: General Internal Medicine, Obstetrics,
Intensive Care, and Cardiac Surgery Intensive Care. For
each service, we monitored care for 12 weeks using
a common method, which was adapted for the service
to ensure relevancy to the patients treated. The
general method included establishment of surveillance
parameters, case ﬁnding, peer review and event classiﬁ-
cation (ﬁgure 1).
Establishment of surveillance parameters
Before starting surveillance, we identiﬁed several service-
speciﬁc surveillance parameters describing surveillance
location, baseline patient information and triggers.
We prespeciﬁed the surveillance location to ensure
consistent and representative case identiﬁcation. On the
Obstetrics service, for example, we monitored patients in
the case-room, the obstetrical operating room, and the
postpartum ward. For Medicine, however, we monitored
patients on the ward only. We also prespeciﬁed whether
we would include care preceding the observation period.
For example, for Intensive Care patients we included
events leading to unit admission.
We prespeciﬁed variables describing baseline patient
information to enable consistent case reviews and permit
future risk adjustments. For example, when we imple-
mented on the Medicine service, we collected informa-
tion regarding the presence of diagnoses associated with
poor outcomes.
30
Most importantly, we prespeciﬁed triggers which
represented the factors we used to prompt case reviews.
Trigger tool methodology has been used successfully in
other institutions to address speciﬁc AE types such as
adverse drug events,
18 19 31e37 hospital-acquired infec-
tions
38 and surgical complications,
39e41 so we adapted
the concept to create a more generalised model for the
identiﬁcation of all types of AEs in various settings. For
each service, we reviewed the literature to identify
previously published risk factors for adverse outcomes. A
multidisciplinary team speciﬁc to each service then
determined the face validity of these triggers and
discussed additional triggers. Consensus was used to
deﬁne the ﬁnal set of triggers. The triggers represent
clinical phenomenon, pharmacy orders and system
events relevant to the patients treated. For example, ‘stat
Caesarean section’ was a system event on the Obstetrics
service, while ‘unplanned OR return’ was used on the
Cardiac Surgery Intensive Care unit. For all services, we
had an ‘Other’ category to account for events that were
not predicted a priori. (See online appendix 1) contains
the triggers we used for the four services.
Figure 1 Prospective clinical
surveillance overview.
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Original researchCase ﬁnding
Case ﬁnding was performed daily Monday to Friday
between 08:00 and 16:00 by a trained nurse (observer).
The observer training consisted of a patient safety
presentation, relevant literature, practice case report
generation and reviews, familiarisation with triggers and
service-speciﬁc integration. We integrated the observer
into the daily activities of the speciﬁc service to ensure
maximal interaction with the providers and opportuni-
ties to observe care yet with minimal disruption to the
providers’ routine. This meant there were slight differ-
ences in how the observations were performed. For
example, in the Intensive Care Unit, observations
occurred at the bedside during morning team rounds,
while on the Medicine service they occurred at the
nursing station. The observer was encouraged to ask
providers for details if they were not volunteered or
documented in the chart.
All patients in the surveillance locations were eligible
for case ﬁnding. The observer captured baseline infor-
mation on all patients admitted to the service. Once data
were entered, the observer monitored the patient until
discharge. The observer identiﬁed triggers using
a combination of three common AE detection methods:
daily interactions with clinicians and administrators to
enquire about or discuss trigger events (prompted and
voluntary reporting), daily chart reviews and direct
observation. If triggers occurred when our observer was
not present, we identiﬁed them based on information
volunteered by providers or from the chart.
Once a trigger was identiﬁed, we captured standard
information describing the case. The observer generated
a case summary using a standard format describing the
patient and event in detail, the response to the event,
the impact of the response and the documented cause of
the response if there was one. This information was
compiled by the observer through discussions with the
relevant staff on the service.
Peer review
Peer review took place weekly. For all reviews, we used
the same deﬁnitions and classiﬁcation systems as those
used in the Harvard Medical Practice Study and other
patient safety studies (See online appendix 2).
1e7 We
used a majority opinion to consolidate the ratings of the
multiple reviewers.
42 Cases were initially classiﬁed as
outcomes (in which a patient experienced some form of
harm, including pain, other distressing symptoms, such
as dyspnoea, or reasonable markers for such symptoms
such as increases in respiratory rate) or process problems
(in which a task did not occur as planned). For example,
if a patient experienced a sudden drop in blood pres-
sure, the event was classiﬁed as an outcome. On the
other hand if a patient missed a dose of an antibiotic but
had no discernible change in status, then the event was
classiﬁed as a process problem. For outcomes, we ﬁrst
assessed whether they were caused by medical care (ie,
an AE). If so, reviewers determined whether it was
preventable (ie, it was caused by error or was avoidable
in some other way). We used six-point Likert scales with
a cut-point of 3 for both of these assessments. For
processes, reviewers determined whether the procedural
or process problem could have caused harm (ie,
a potential AE). Again, we used a six-point Likert scale
with a cut-point of 3 for this assessment (ie, a score of 4,
5 or 6 indicated a process problem).
Event classiﬁcation
Event classiﬁcation occurred following categorisation of
cases as AEs, preventable AEs or potential AEs. For these
cases, the observer deﬁned the event’s severity and type.
For severity, events caused one of the following levels of
increasing harm: none; laboratory abnormalities only;
symptoms only; temporary disability; permanent
disability; or death. Events were also classiﬁed according
to one or more of the following types: hospital-acquired
infection; adverse drug event; procedural complication;
operative complication; diagnostic error; management
error; anaesthetic complication; obstetrical injury; and
system design ﬂaw. As almost all errors could be argued
to be system errors, only those events that could not be
assigned to another type were deemed to be system
design ﬂaws.
Analysis
We described patient baseline characteristics using
median and IQR for continuous variables and frequency
distributions for categorical variables. We described
events in terms of preventability, severity and type for
each service overall. We calculated the risk of experi-
encing at least one event per hospital encounter. We also
calculated the event rate in terms of events per patient
day of observation. We used SAS version 9.0 for all data
management and analyses.
RESULTS
Table 1 describes the patient populations in terms of
their baseline characteristics. There were important
differences between services. We observed many more
patients in Medicine (n¼453) and Obstetrics (n¼516)
than Cardiac Surgery (n¼226) or Intensive Care
(n¼211). Individual patients spent more days on Medi-
cine than Intensive Care, Obstetrics and Cardiac
Surgery, with median lengths of stay on the monitored
unit of 8 days, 4.8 days, 2.4 days and 2.1 days, respec-
tively. The indications for admission varied extensively
between the four services. Medicine patients were older
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Original research(median age on Medicine, Cardiac Surgery, Intensive
Care and Obstetrics was 74, 70, 66 and 30 years, respec-
tively) and frailer (proportion of patients with
a Charlson Index of 3 on Medicine, Cardiac Surgery and
Intensive Care was 24%, 3% and 7%, respectively).
Table 2 demonstrates the overall and service-speciﬁc
AE risk and rate. 192 patients (13.7%) encountered 245
AEs (2.6 events per 100 patient days), 86 patients (6.1%)
encountered 88 preventable AEs (0.9 events per 100
patient days), and 75 patients (5.3%) encountered 81
potential AEs (0.9 events per 100 patient days). The
greatest number of events was observed on the Medicine
service, which accounted for 63% (75/119) of patients
with AEs, 56% of (48/86) patients with preventable AEs
and 56% (40/75) of patients with potential AEs.
The risk and rate of all AEs and preventable AEs were
highest for the Intensive Care unit. Of the 211 patients
observed on Intensive Care, 52 (24.6%) experienced at
least one AE, and 23 (10.9%) experienced a preventable
AE. The corresponding event rates were 4.5 and 1.4 per
100 patient days for AEs and preventable AEs, respec-
tively. The lowest risk and rate of events occurred on the
Obstetrics service. Of the 516 patients observed on
Obstetrics, 20 (3.9%) experienced at least one AE, and
seven (1.4%) experienced a preventable AE. The corre-
sponding event rates were 1.5 and 0.5 per 100 patient
days for AEs and preventable AEs, respectively.
Table 3 describes the severity of all AEs detected. Of all
245 events detected, six (2.5%) resulted in/were associ-
ated with/potentially led to death, and 16 (6.6%) led to
permanent disability. The vast majority of events resulted
in symptoms only (n¼75, 30.7%) or led to temporary
disability (n¼112, 45.9%). The majority of events that
led to death or permanent disability occurred in the two
critical care areas (Cardiac Surgery Intensive Care and
Intensive Care). The risk of AEs causing permanent
disability or death varied 24-fold across services:
Cardiac Surgery Intensive Care (11/226¼4.9%), Inten-
sive Care (8/211¼3.8%), Medicine (2/453¼0.4%),
Obstetrics (1/516¼0.2%).
Table 3 also describes the types of AEs identiﬁed.
There were important proportions of all AE types, but
overall the most common types were therapeutic errors,
procedural complications, and adverse drug events.
Within each service, the top three AE types differed, and
no service shared the most frequent AE type. For Cardiac
Surgery, the top three types were surgical complications
(47%), hospital-acquired infections (19%) and proce-
dural complications (11%). For Intensive Care, the top
three types were hospital-acquired infections (25%),
procedural complications (24%) and therapeutic errors
(19%). For Medicine, the top three types were adverse
drug events (30%), therapeutic errors (24%) and
procedural complications (12%). For Obstetrics, the top
three types were therapeutic errors (36%), procedural
complications (32%) and adverse drug events (27%).
DISCUSSION
We used clinical surveillance to detect AEs on four
hospital services. AE risk per encounter was 13% with
a range of 4% to 25% depending on service. Overall,
36% of AEs were preventable, though this was highly
variable between services, ranging from 13% to 56%.
General Internal Medicine had the greatest number of
AEs but also had the highest number of patients and
comorbidities. After controlling for length of stay and
Table 2 Adverse event (AE) risk and rate
Overall
Cardiac
surgery
Intensive
care
Internal
medicine Obstetrics
p value
(c
2 test)
Risk* N (%)
Patients observed 1406 226 211 453 516
Patients with at least one AE 192 (13.7%) 45 (19.9%) 52 (24.6%) 75 (16.6%) 20 (3.9%) <0.001
Patients with at least one
preventable AE
86 (6.1%) 8 (3.5%) 23 (10.9%) 48 (10.6%) 7 (1.4%) <0.001
Patients with at least one
potential AE
75 (5.3%) 6 (2.7%) 17 (8.1%) 40 (8.8%) 12 (2.3%) <0.001
Ratey
Days of observation 9300 1234 1592 5026 1448
AE rate (per 100 patient days) 245 (2.6) 62 (5.0) 72 (4.5) 89 (1.8) 22 (1.5) <0.001
Preventable AE rate
(per 100 patient days)
88 (0.9) 8 (0.6) 23 (1.4) 50 (1.0) 7 (0.5) 0.03
Potential AE rate
(per 100 patient days)
81 (0.9) 7 (0.6) 20 (1.3) 42 (0.8) 12 (0.8) 0.24
*Risk was calculated as the number of patients with at least one event divided by the total number of patients observed.
yRate reported as events per 100 patient days, which was calculated as the number of events divided by the number of patient days of
observation multiplied by 100.
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Original researchthe number of patients observed, the risk of AEs,
including those with the most severe consequences, was
greatest in the two critical care areas. There were
differences in the types of AEs identiﬁed; however,
therapeutic errors were common in all subgroups
studied. Finally, clinical surveillance identiﬁed an
important number of potential AEs.
These ﬁndings are important because they identify
ample opportunities for quality improvement. We found
a greater AE risk than most previous studies of AEs which
have tended to rely solely on chart review.
1e7 We used
a clinical observer to identify events within 24 h of their
occurrence, and reviewed them within 7 days of their
identiﬁcation. The timely identiﬁcation of problems
would ultimately mean a more rapid response to rectify
them. The reviews were performed by clinicians who
knew the clinical setting and were well respected by their
local peers. We believe that these factors resulted in
classiﬁcations with a much greater degree of face validity
than existing methods to identify AEs (such as incident
reports and chart reviews). These factors also led us to
identify a signiﬁcantly greater proportion of events
attributed to diagnostic and therapeutic errors, than
prior studies. Furthermore, the systematic nature of our
data collection ensured our methods were less biased
than morbidity and mortality reviews or closed-claims
analysis.
15 43 44
Our study supports the concept that improvement
strategies must be locally developed and must target
speciﬁc problems. We found that AE risk and type varied
by service. The underlying explanation for this ﬁnding
likely relates to the frequency of underlying processes
occurring within these areas that in turn lead to more
opportunities to cause harm. Regardless of the cause, it
follows that solutions will also necessarily vary. For
example, in the Cardiac Surgery Intensive Care unit,
interventions should be directed to preventing certain
types of surgical complications. On the Medicine service,
interventions that focus speciﬁcally on reducing errors
related to the medication administration process would
be most beneﬁcial. The conclusion that errors and their
solutions vary by patient service is intuitively obvious but
is often not incorporated in the ‘top down’ approaches
to improve quality and safety taken by accreditation
organisations or other regulators.
Our study also supports the conclusion that priority
setting, as it pertains to safety improvement, must occur
in a highly strategic manner. The greatest number of AEs
occurred on the service with the frailest patients. Effec-
tive interventions to improve safety in these patients
would have the largest reduction on the institutional
number of events. However, after controlling for the
number of patients and length of observation, these
patients had a risk of events similar to the least frail
patients. The highest event risk and the most severe
events occurred in services that had very invasive thera-
pies and where patients were most acutely ill. Therefore,
efforts to prevent injuries in these groups might be more
efﬁcient and associated with a greater overall impact in
terms of reducing the economic burden of AEs. For all
these reasons, organisations will have to be very clear
about their goals when targeting the safety problems
they hope to solve.
Finally, this research has highlighted the feasibility of
clinical surveillance. We used a comprehensive strategy
involving the use of direct observation, voluntary and
prompted reporting, as well as daily chart reviews. This
combination of AE detection methods has been
Table 3 Adverse event severity and type
Overall
N (%)
Cardiac
surgery N (%)
Intensive
care N (%)
Medicine
N (%)
Obstetrics
N (%)
p Value
(c
2 test)
Total 245 (100) 62 (100) 72 (100) 89 (100) 22 (100)
Severity <0.001
Lab/physiological 36 (14.7) 2 (3.2) 10 (13.9) 23 (25.8) 1 (4.6)
Symptoms 75 (30.7) 9 (14.5) 18 (25.0) 38 (42.7) 10 (45.5)
Temporary 112 (45.9) 40 (64.5) 36 (50.0) 26 (29.2) 10 (45.5)
Permanent 16 (6.6) 8 (12.9) 7 (9.7) 0 (0.0) 1 (4.6)
Death 6 (2.5) 3 (4.8) 1 (1.4) 2 (2.3) 0 (0.0)
Type <0.001
Procedural complication 42 (17.14) 7 (11.3) 17 (23.6) 11 (12.4) 7 (31.8)
Infection 37 (15.1) 12 (19.4) 18 (25.0) 7 (7.9) 0 (0.0)
Adverse drug event 46 (18.8) 4 (6.5) 9 (12.5) 27 (30.3) 6 (27.3)
Therapeutic error 49 (20.0) 5 (8.1) 14 (19.4) 22 (24.7) 8 (36.4)
Surgical complication 37 (15.1) 29 (46.8) 7 (9.7) 0 (0.0) 1 (4.6)
Diagnostic error 10 (4.1) 3 (4.8) 4 (5.6) 3 (3.4) 0 (0.0)
Falls 10 (4.1) 0 (0.0) 0 (0.0) 10 (11.2) 0 (0.0)
System problem 11 (4.5) 2 (3.2) 3 (4.2) 6 (6.7) 0 (0.0)
Pressure ulcer 3 (1.2) 0 (0.0) 0 (0.0) 3 (3.4) 0 (0.0)
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15 and serves to increase the
overall performance of the monitoring system. Our
programme was well accepted in the four services
studied with very little ﬁnancial support (the clinical
observer was a funded position). However, all other
functions required to maintain the process were volun-
tary, and there was very little infrastructure support
required. There was no evidence that providers who
were being observed were overtly or covertly averse to
the programme or changed their behaviours. In fact, the
methodology was so well received that our institution
wanted to and is currently taking steps to implement it
on other services.
Our ﬁndings are important in that we used a repro-
ducible method of case detection and case review
applying a standard method of classiﬁcation to facilitate
comparison. However, there are three important limita-
tions which we would like to highlight. First, we are
uncertain of the programme’s reliability. Threats to
reliability include the observer and peer-review
processes. We attempted to mitigate these concerns
through standardisation of the process of observation
using triggers and case report forms; and, for the peer
review, the use of multiple reviewers. These approaches
have been successful in improving reliability in prior
settings. However, we recommend further research
before our method be adopted by health systems to
compare institutions. Second, the generalisability of our
surveillance feasibility is unknown, particularly because it
was performed using a single observer. Even though we
successfully implemented our programme within
multiple settings in different facilities, it is possible that
other settings may create challenges. Further work is
recommended to establish whether the programme can
be successfully adapted within non-teaching hospitals
and in different health systems. Third, the observer
cannot be everywhere at once and may miss some events
as they are happening. This means the programme
cannot be used to intervene systematically and directly in
patient care when it does not meet the standard.
However, this is not the stated purpose of the
programme. Furthermore, if cases are detected in which
an immediate intervention is warranted, then this
appropriate response should be easily performed. For
example, we identiﬁed a few instances when a critical
laboratory abnormality had not been recognised and
simply brought it to the attention of the treating team.
In summary, our study supports the conclusion that
clinical surveillance appears to be an effective means of
detecting patient safety issues. Before making a general
recommendation for widely adopting this method, we
recommend further evaluations to address four issues.
First, we recommend comparing the ﬁndings of clinical
surveillance with other methods of identifying patient
safety events. Second, we recommend an economic
analysis to determine the most efﬁcient method of
adverse event detection. Third, we would recommend
evaluations of this method in different hospitals. Finally,
and most importantly, we recommend studies to deter-
mine if adverse event detection leads to improvement in
patient outcomes.
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